PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Prostaglandins & other lipid mediators

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PROSTAGLANDINS.2007.10.009PMID 18160324PMCID PMC2277510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Load-induced focal adhesion mechanotransduction is altered with aging in the Fischer 344/NNiaHSd × Brown Norway/BiNia rat aorta

  2007cited by this paper
• cAMP-response element-binding protein mediates prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells.

  2005cited by this paper
• A Novel Role for Nuclear Factor of Activated T Cells in Receptor Tyrosine Kinase and G Protein-coupled Receptor Agonist-induced Vascular Smooth Muscle Cell Motility*

  2004cited by this paper
• The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.

  2004cited by this paper
• Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3β

  2004cited by this paper
• Hydrogen peroxide mediates arsenite activation of p70(s6k) and extracellular signal-regulated kinase.

  2003cited by this paper
• Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease (review).

  2003cited by this paper
• Real-Time Intracellular Ca2+ Mobilization by Travoprost Acid, Bimatoprost, Unoprostone, and Other Analogs via Endogenous Mouse, Rat, and Cloned Human FP Prostaglandin Receptors

  2003cited by this paper
• Predominant Nuclear Localization of Mammalian Target of Rapamycin in Normal and Malignant Cells in Culture*

  2002cited by this paper
• NADPH Oxidase Is Involved in Prostaglandin F2α-induced Hypertrophy of Vascular Smooth Muscle Cells

  2002cited by this paper
• Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

  2002cited by this paper
• Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.

  2002cited by this paper
• Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells.

  2002cited by this paper
• Differential role of hydrogen peroxide in UV-induced signal transduction

  2002cited by this paper
• GSK-3β negatively regulates skeletal myotube hypertrophy

  2002cited by this paper
• Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 *

  2002influential reference
• NADPH oxidase is involved in prostaglandin F2alpha-induced hypertrophy of vascular smooth muscle cells: induction of NOX1 by PGF2alpha.

  2002influential reference
• GSK-3beta negatively regulates skeletal myotube hypertrophy.

  2002cited by this paper
• Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo

  2002cited by this paper
• Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways

  2001cited by this paper
• Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

  2001cited by this paper
• Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways

  2001cited by this paper
• The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus

  2001cited by this paper
• Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

  2001cited by this paper
• Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc*

  2001cited by this paper
• Prostanoid receptors: subtypes and signaling.

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Role and relation of p70 S6 and extracellular signal-regulated kinases in the phenotypic changes of hypertrophy of cardiac myocytes.

  2000cited by this paper
• Nuclear targeting of proteins: how many different signals?

  2000cited by this paper
• Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells.

  1999cited by this paper
• Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle.

  1999cited by this paper
• Activation of Akt/protein kinase B after stimulation with angiotensin II in vascular smooth muscle cells.

  1999cited by this paper
• A Potential Role for Extracellular Signal-regulated Kinases in Prostaglandin F2α-induced Protein Synthesis in Smooth Muscle Cells*

  1999influential reference
• Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase‐3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin

  1998cited by this paper
• Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways.

  1998cited by this paper
• Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

  1998cited by this paper
• Prostaglandin F2α (PGF2α) and the Isoprostane, 8,12-iso-Isoprostane F2α-III, Induce Cardiomyocyte Hypertrophy

  1998cited by this paper
• Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells.

  1997cited by this paper
• Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k

  1997cited by this paper
• Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.

  1997cited by this paper
• Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes.

  1996cited by this paper
• Activation of p70 S6 protein kinase is necessary for angiotensin II‐induced hypertrophy in neonatal rat cardiac myocytes

  1996cited by this paper
• Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo.

  1996cited by this paper
• Role of p70 S6 Protein Kinase in Angiotensin II-induced Protein Synthesis in Vascular Smooth Muscle Cells (*)

  1995cited by this paper
• Cloning and expression of a cDNA for the human prostanoid FP receptor.

  1994cited by this paper
• Cloning and expression of a cDNA for the human prostanoid IP receptor.

  1994cited by this paper
• Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.

  1992cited by this paper
• Flow Cytometric Analysis of Respiratory Burst Activity in Phagocytes With Hydroethidine and 2′,7′‐Dichlorofluorescin

  1990cited by this paper
• Stretch-induced prostaglandins and protein turnover in cultured skeletal muscle.

  1990cited by this paper
• Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion.

  1989cited by this paper
• Myocardial biosynthesis of prostacyclin and the influence of cardiac loading and drugs.

  1988cited by this paper
• Hormonal regulation of myoblast proliferation and myotube production in vivo: influence of prostaglandins.

  1987cited by this paper
• Influences of inactivity and indomethacin on soleus phosphatidylethanolamine and size.

  1986cited by this paper
• Heart adaptation to acute pressure overload: an involvement of endogenous prostaglandins.

  1979cited by this paper
• Effects of verapamil and aspirin on experimental chronic hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.

  1979cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper

• Oxylipins are Associated with Poor Right Ventricular to Pulmonary Artery Coupling and Adverse Outcomes in Heart Failure with Preserved Ejection Fraction.

  2025cites this paper
• Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

  2023cites this paper
• Lipids Alterations Associated with Metformin in Healthy Subjects: An Investigation Using Mass Spectrometry Shotgun Approach

  2022cites this paper
• Assessment of prostaglandin F2‐alpha (PGF2α) in lesional and nonlesional skin of vitiligo patients

  2022cites this paper
• The antagonism of prostaglandin FP receptors inhibits the evolution of spreading depolarization in an experimental model of global forebrain ischemia.

  2020cites this paper
• Effect of Prostanoids on Human Platelet Function: An Overview

  2020cites this paper
• Prostaglandin D2 stimulates phenotypic changes in vascular smooth muscle cells

  2019cites this paper
• NADPH oxidase in the vasculature: Expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension.

  2019cites this paper
• High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.

  2018cites this paper
• Natriuretic peptide receptor‐C‐mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS‐associated signaling

  2017cites this paper
• Natriuretic peptide receptor-C activation regulates vascular smooth muscle cell hypertrophy : molecular mechanisms

  2017influential citation
• Oxidative stress contributes to the enhanced expression of Gqα/PLCβ1 proteins and hypertrophy of VSMC from SHR: role of growth factor receptor transactivation.

  2016cites this paper
• Oxidative Stress Modulation Through Habitual Physical Activity.

  2016cites this paper
• ROS inhibit autophagy by downregulating ULK1 mediated by the phosphorylation of p53 in selenite-treated NB4 cells

  2014cites this paper
• Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes

  2014cites this paper
• Morphologic Manifestations of Gene-Specific Molecular Alterations (“Genetic Addictions”) in Mouse Models of Disease

  2012cites this paper
• Inflammatory signaling in skeletal muscle cell growth

  2012influential citation
• Prostaglandin F2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy.

  2011cites this paper
• Development of a non-invasive method to detect pericellular spatial oxygen gradients using FLIM

  2011cites this paper
• Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease.

  2011cites this paper
• Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt-p70s6k signaling and PGF2α.

  2010cites this paper
• GPCR signalling to the translation machinery.

  2010cites this paper
• PG F2α Receptor: A Promising Therapeutic Target for Cardiovascular Disease

  2010cites this paper
• Prostaglandin E2 and prostaglandin F2α differentially modulate matrix metabolism of human nucleus pulposus cells

  2010cites this paper
• Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-&agr; Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells

  2009cites this paper